ASSOCIATION BETWEEN FOVEAL MICROSTRUCTURE AND VISUAL OUTCOME IN AGE-RELATED MACULAR DEGENERATION

Purpose: To investigate the correlation between foveal photoreceptor integrity and final visual acuity after treatment of eyes with neovascular age-related macular degeneration, and to determine the visual prognostic factors. Methods: We retrospectively studied 40 eyes of 40 patients with neovascular age-related macular degeneration who were treated successfully with intravitreal anti-vascular endothelial growth factor injection. Using spectral-domain optical coherence tomography, the eyes were categorized into three groups at the final visit, the V group with a completely visible photoreceptor inner and outer segment junction (IS/OS), the P group with a partially detected IS/OS, and the I group with an invisible IS/OS. The length of disrupted IS/OS and external limiting membrane, central macular thickness, and choroidal neovascularization size at the initial and final visits were measured. Retinal pigment epithelium regularity and outer nuclear layer thickness at the final visit were also evaluated. Results: Final visual acuity was closely associated with IS/OS integrity at the final visit. Final visual acuity (logarithm of minimum angle of resolution) in the V group (0.13 ± 0.10) was better than that in the P group (0.41 ± 0.31), and final visual acuity in the P group was better than that in the I group (0.97 ± 0.51) (P < 0.001). Shorter disrupted IS/OS and external limiting membrane length at the final visit were closely associated with better final visual acuity. Preservation of the IS/OS and external limiting membrane, thinner central macular thickness, and shorter choroidal neovascularization height before treatment were associated with intact photoreceptor integrity after resolution of exudation. However, central macular thickness, outer nuclear layer thickness, and retinal pigment epithelium regularity at the final visit had no significant correlation with photoreceptor integrity. Conclusion: Foveal photoreceptor integrity was closely associated with final visual acuity in neovascular age-related macular degeneration after treatment. Initial visual acuity, IS/OS and external limiting membrane integrity, central macular thickness, and choroidal neovascularization height were correlated with final photoreceptor integrity, and they would be visual prognostic factors after resolution of exudation.

[1]  Masayuki Hata,et al.  The significance of external limiting membrane status for visual acuity in age-related macular degeneration. , 2010, American journal of ophthalmology.

[2]  S. Kishi,et al.  CORRELATION BETWEEN VISUAL ACUITY AND FOVEAL MICROSTRUCTURAL CHANGES IN DIABETIC MACULAR EDEMA , 2010, Retina.

[3]  Reginald Birngruber,et al.  Effects on choroidal neovascularization after anti-VEGF Upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomography. , 2010, Investigative Ophthalmology and Visual Science.

[4]  Tom Chang,et al.  SHORT-TERM EFFECTIVENESS OF INTRAVITREAL BEVACIZUMAB VERSUS RANIBIZUMAB INJECTIONS FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2009, Retina.

[5]  S. Kishi,et al.  Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. , 2009, American journal of ophthalmology.

[6]  A. Tsujikawa,et al.  Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. , 2009, American journal of ophthalmology.

[7]  C. Valmaggia,et al.  The Treatment of Choroidal Neovascularizations in Age-Related Macular Degeneration using either Avastin or Lucentis , 2009, Klinische Monatsblatter fur Augenheilkunde.

[8]  Y. Tano,et al.  Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. , 2009, Ophthalmology.

[9]  P. Kaiser,et al.  Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration , 2009, British Journal of Ophthalmology.

[10]  A. Tsujikawa,et al.  Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion , 2008, Clinical & experimental ophthalmology.

[11]  A. Tsujikawa,et al.  INTEGRITY OF FOVEAL PHOTORECEPTOR LAYER IN CENTRAL RETINAL VEIN OCCLUSION , 2008, Retina.

[12]  J. Roider,et al.  Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways. , 2008, Investigative ophthalmology & visual science.

[13]  Richard F Spaide,et al.  Disruption of the Photoreceptor Inner Segment–Outer Segment Junction in Eyes With Macular Holes , 2008, Retina.

[14]  U Chakravarthy,et al.  Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation , 2008, British Journal of Ophthalmology.

[15]  T. Peto,et al.  Autofluorescence imaging in age-related macular degeneration complicated by choroidal neovascularization: a prospective study. , 2008, Ophthalmology.

[16]  Kazuaki Miyamoto,et al.  Three-dimensional imaging of cystoid macular edema in retinal vein occlusion. , 2008, Ophthalmology (Rochester, Minn.).

[17]  Paul G. Updike,et al.  Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration. , 2008, Ophthalmology.

[18]  Peter K Kaiser,et al.  Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. , 2007, Ophthalmology.

[19]  T. Yatagai,et al.  [Improved visualization of foveal pathologies using fourier-domain optical coherence tomography]. , 2007, Nippon Ganka Gakkai zasshi.

[20]  A. Tsujikawa,et al.  Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion , 2007, British Journal of Ophthalmology.

[21]  T. Yatagai,et al.  Three-dimensional imaging of macular holes with high-speed optical coherence tomography. , 2007, Ophthalmology.

[22]  J. Slakter,et al.  Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. , 2006, Ophthalmology.

[23]  Richard F Spaide,et al.  OPTICAL COHERENCE TOMOGRAPHY IN UNILATERAL RESOLVED CENTRAL SEROUS CHORIORETINOPATHY , 2005, Retina.

[24]  G. Ravera,et al.  The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. , 2005, American journal of ophthalmology.

[25]  U. Schmidt-Erfurth,et al.  Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. , 2004, American journal of ophthalmology.

[26]  H. Heimann,et al.  Concentric retinal pigment epithelium atrophy after a single photodynamic therapy , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.

[27]  Joan W. Miller,et al.  Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. , 2002, Investigative ophthalmology & visual science.

[28]  Neil M Bressler,et al.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.

[29]  N. Bressler,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.

[30]  T. Stokkermans,et al.  Treatment of age-related macular degeneration. , 2000, Clinical eye and vision care.

[31]  T J Flotte,et al.  Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. , 1999, Ophthalmology.

[32]  A C Bird,et al.  Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. , 1975, The British journal of ophthalmology.